These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3500185)

  • 1. Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.
    Walsh PN; Sinha D; Kueppers F; Seaman FS; Blankstein KB
    J Clin Invest; 1987 Dec; 80(6):1578-86. PubMed ID: 3500185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.
    Scott CF; Schapira M; James HL; Cohen AB; Colman RW
    J Clin Invest; 1982 Apr; 69(4):844-52. PubMed ID: 7076850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.
    Walsh PN; Sinha D; Koshy A; Seaman FS; Bradford H
    Blood; 1986 Jul; 68(1):225-30. PubMed ID: 3487355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.
    Cronlund AL; Walsh PN
    Biochemistry; 1992 Feb; 31(6):1685-94. PubMed ID: 1737024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
    Baglia FA; Sinha D; Walsh PN
    Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of platelets in the activation of human blood coagulation factor IX by factor XIa.
    Soons H; Janssen-Claessen T; Hemker HC; Tans G
    Blood; 1986 Jul; 68(1):140-8. PubMed ID: 3487352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
    Schapira M; Scott CF; Colman RW
    Trans Assoc Am Physicians; 1981; 94():190-7. PubMed ID: 6979819
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.
    Sinha D; Seaman FS; Koshy A; Knight LC; Walsh PN
    J Clin Invest; 1984 Jun; 73(6):1550-6. PubMed ID: 6609936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human blood coagulation factor XIa by C-1 inhibitor.
    Meijers JC; Vlooswijk RA; Bouma BN
    Biochemistry; 1988 Feb; 27(3):959-63. PubMed ID: 3259145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-mediated trigger mechanisms in the contact phase of blood coagulation.
    Walsh PN
    Semin Thromb Hemost; 1987 Jan; 13(1):86-94. PubMed ID: 3031818
    [No Abstract]   [Full Text] [Related]  

  • 11. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells.
    Berrettini M; Schleef RR; Heeb MJ; Hopmeier P; Griffin JH
    J Biol Chem; 1992 Oct; 267(28):19833-9. PubMed ID: 1400299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.
    Sinha D; Koshy A; Seaman FS; Walsh PN
    J Biol Chem; 1985 Sep; 260(19):10714-9. PubMed ID: 3875611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine monoclonal antibodies to human factor XI.
    Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
    Thromb Res; 1986 Apr; 42(2):225-34. PubMed ID: 3487138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate-dependent modulation of the mechanism of factor XIa inhibition.
    Pedicord DL; Seiffert D; Blat Y
    Biochemistry; 2004 Sep; 43(37):11883-8. PubMed ID: 15362874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
    Baglia FA; Walsh PN
    J Biol Chem; 2000 Jul; 275(27):20514-9. PubMed ID: 10781579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.
    Miller TN; Sinha D; Baird TR; Walsh PN
    Biochemistry; 2007 Dec; 46(50):14450-60. PubMed ID: 18020374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential.
    Gailani D; Ho D; Sun MF; Cheng Q; Walsh PN
    Blood; 2001 May; 97(10):3117-22. PubMed ID: 11342438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of high molecular weight kininogen in contact activation.
    van Iwaarden F; Bouma BN
    Semin Thromb Hemost; 1987 Jan; 13(1):15-24. PubMed ID: 2436301
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrinsic versus extrinsic coagulation. Kinetic considerations.
    Warn-Cramer BJ; Bajaj SP
    Biochem J; 1986 Nov; 239(3):757-62. PubMed ID: 3493767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.